Transformative Partnership: Zydus and Guardant Health Join Forces for Cancer Testing in India and Nepal

▴ Cancer Testing in India
As India and Nepal grapple with the growing burden of cancer cases, initiatives like these are pivotal in steering the healthcare landscape towards innovative solutions and improved patient care

In a remarkable move towards advancing precision medicine, Zydus and Guardant Health have entered into a co-marketing agreement, aiming to promote the Guardant360 portfolio of liquid and tissue biopsy tests across India and Nepal. This collaboration, as announced through an exchange filing, highlights the commitment to enhancing patient outcomes and the field of precision oncology in the region.

Comprehensive Genomic Profiling at the Forefront: The tests highlighted in this partnership include Guardant360 and Guardant360 TissueNext, offering comprehensive genomic profiling (CGP), along with the Guardant360 Response test designed for monitoring treatment response. These cutting-edge tests play a crucial role in providing oncologists with valuable insights to make informed decisions for patients dealing with advanced cancer.

Addressing a Growing Health Challenge: Cancer poses a significant health challenge in India and Nepal, with alarming statistics revealing that one out of nine Indians may develop cancer in their lifetime, and over 20,000 individuals in Nepal are diagnosed with cancer annually. Simranjit Singh, CEO of Guardant Health Asia, Middle East, and Africa, emphasizes the pressing need to tackle this issue.

Innovative Solutions for Improved Patient Care: Guardant360, a minimally invasive liquid biopsy test, stands out by offering comprehensive genomic profiling of solid tumours through the analysis of circulating tumour DNA (ctDNA) from a simple blood draw. Guardant360 TissueNext complements this by providing CGP results from a tumour tissue biopsy, offering actionable information to doctors when tissue testing is necessary. The Guardant360 Response test serves as a vital monitoring tool, enabling oncologists to track a patient's treatment response over time.

A Collective Step Toward Precision Medicine: By pooling their resources and expertise, Zydus and Guardant Health aspire to empower oncologists with the necessary tools to navigate treatment decisions effectively. This collaboration signifies a shared dedication to advancing precision medicine and ultimately making a positive impact on cancer care in the region.

As India and Nepal grapple with the growing burden of cancer cases, initiatives like these are pivotal in steering the healthcare landscape towards innovative solutions and improved patient care. The collaboration between Zydus and Guardant Health marks a significant stride in the realm of precision medicine, offering a ray of hope for cancer patients in India and Nepal. With a focus on comprehensive genomic profiling through tests like Guardant360 and Guardant360 TissueNext, the collaboration addresses the pressing need for precise and informed decision-making in oncology. The inclusion of the Guardant360 Response test further underlines the commitment to monitoring treatment responses over time, ensuring a tailored approach to each patient's journey.

Tags : #zydus #guardanthealth #india #nepal #cancer #cancertesting #patientcare #cancerawareness #medicircle

About the Author

Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...


Trending Now

Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!April 13, 2024
Ministry of Health Dispels Misinformation on Medicine Price Surge from April 1April 13, 2024
India’s First Indigenous CAR T-Cell Therapy Launched By President Droupadi Murmu: A New Hope in Cancer TreatmentApril 12, 2024
Investigation Launched After Cataract Surgery Patients Experience Side-Effects in IndoreApril 12, 2024
The Reality of Protein Supplements in India: Mislabeling, Toxins, and Quality ChallengesApril 12, 2024
A Majority Of People Are Piling Up Weight Despite Adhering To A Healthy Lifestyle, Opt For These Vital Tests: ExpertsApril 11, 2024
Fighting Tuberculosis: IHLD and Krafton India Join Forces for Active Case DetectionApril 11, 2024
ICMR Study Reveals Blood Pressure Monitoring Gaps in IndiaApril 11, 2024
Innovative Procedure at KGMU Saves Man Impaled by Iron Rod: Beating Heart Surgery SuccessApril 11, 2024
Heart-Healthy Choices: How Salt Substitutes Can Prolong Your LifeApril 11, 2024
Unveiling Cancer Patterns in Families of Men with Fertility ChallengesApril 11, 2024
10 secrets of Successful Healthcare Branding and advertising campaignsApril 10, 2024
Global Hepatitis Crisis: India Ranks Second in Cases – WHO Report 2024April 10, 2024
Accelerated Ageing and Cancer Risk: New Perspectives from AACR 2024April 10, 2024
Man Hospitalized with Rare Bacterial Infection After Rat Bite: What You Need to KnowApril 10, 2024
Enhanced rock weathering results in higher crop yields and improved crop healthApril 09, 2024
Unlocking Health and Wealth - The Intersection of Digital Innovation in Healthcare and Finance for a Resilient IndiaApril 09, 2024
University of Exeter announces scholarships valued at over £10,000 for Indian StudentsApril 09, 2024
Thai Lion Air Extends Ground Handling Partnership with Çelebi India for Handling Cochin OperationsApril 09, 2024
Inclusion Carnival Illuminates Abilities and Awareness: A Vibrant Celebration of DiversityApril 08, 2024